Clinical Trial Update: Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing continuous infusion versus intermittent bolus infusion of a recombinant protein-free factor VIII in Hemophilia A patients undergoing maj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant protein-free factor VIII (rAHF-PFM) (recombinant protein-free factor VIII)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 4 | Status: COMPLETED | Results posted: 2017-05-19